Salisbury Franklin Cary jr 4
4 · CASI Pharmaceuticals, Inc. · Filed Jul 3, 2018
Insider Transaction Report
Form 4
Salisbury Franklin Cary jr
Director
Transactions
- Award
Stock Options (Right to Buy)
[F1]2018-06-29+35,000→ 35,000 totalExercise: $8.23Exp: 2028-06-29→ Common Stock (35,000 underlying)
Footnotes (1)
- [F1]Stock option award will vest ratably quarterly to the end of one year.
Signature
/s/ Cynthia W. Hu, attorney-in-fact for Franklin C. Salisbury, Jr.|2018-07-03